Acapedia

Cytology has always been powerful for early cancer detection — but limited by subjective interpretation.

A new study in Nature introduces a clinical-grade autonomous cytopathology system that combines:

• Whole-slide 3D edge tomography

• Real-time compression + edge computing

• End-to-end AI cell detection and classification

• Population-level morphological profiling (CMD framework)

Results show >0.99 AUC at single-cell level and strong multicentre slide-level performance across 1,100+ samples.

This is not just “AI assistance.”

It’s a step toward fully autonomous, scalable, and objective cytology workflows.


The real question:

Are we ready to trust autonomous triage in routine cancer screening?

https://www.nature.com/articles/s41586-025-10094-y

Clinical-grade autonomous cytopathology through whole-slide edge tomography - Nature This study presents a clinical-grade autonomous pipeline combining high-resolution whole-slide tomography, edge computing and artificial intelligence, achieving high accuracy in cervical cytology and enabling scalable and objective diagnostics.

🎓 1.0 CME Credit | Breast Imaging & Elastography

This article is available for 1.0 CME credit and reviews the diagnostic value of the elastography strain rate (SR) ratio in differentiating benign and malignant BI-RADS-US 3–4 breast masses.

📊 Key learning points:

• Optimal SR cut-off value: 3.57

• Sensitivity: 85.7%

• Specificity: 98.8%

• Diagnostic accuracy: 93.6%

• Excellent agreement with pathology (κ = 0.864)

• Strong diagnostic performance across BI-RADS categories

(AUC range: 0.793–0.985)

🔍 The study demonstrates how quantitative elastography can enhance diagnostic confidence, particularly in the challenging BI-RADS 3–4 spectrum, and serves as a valuable CME learning resource for breast imaging professionals.

🩻 Specialty: Radiology – Breast Imaging

🎯 Focus: Elastography, elasticity imaging techniques

🎓 CME Credit: 1.0

https://www.acapedia.com/article/elastography-strain-ratio-bi-rads-breast-masses

Acapedia CME | Elastography in BI-RADS 3-4 Breast Mass Diagnostics Earn CME credits with Acapedia! Delve into our comprehensive study on the diagnostic value of elastography strain rate in BI-RADS 3-4 breast masses. Start learning now!

Dual gene deletion reveals potential biomarkers for predicting immunotherapy success

Why do some tumors respond dramatically to immunotherapy while others remain resistant?

This study from the Wellcome Trust Sanger Institute, in collaboration with Open Targets and the Netherlands Cancer Institute, provides a compelling answer by uncovering tumor-intrinsic genetic factors that shape immune response.

What’s new in the approach

◉ Genome-wide CRISPR-Cas9 screens performed under immune selection

◉ A novel tumor–immune co-culture system, combining patient-derived tumor cells with autologous T cells

◉ Direct measurement of immune-mediated cancer cell killing

Key insights

◉ Loss of CHD1 or MAP3K7 (TAK1) makes cancer cells significantly more sensitive to immune attack

◉ Dual loss amplifies this effect, particularly under IFN-γ signaling and T cell pressure

◉ In mouse models, tumors lacking these genes show stronger responses to immune checkpoint blockade (ICB) and increased infiltration of cytotoxic T cells

◉ Analysis of patient data reveals that low CHD1 or MAP3K7 expression correlates with better clinical response to immunotherapy

These findings position CHD1 and MAP3K7 as promising biomarkers for predicting which patients are most likely to benefit from immunotherapy — and point toward new strategies for personalized cancer treatment.

Authors:

Alex Watterson, Gabriele Picco, Vivien Veninga, Youhani Samarakoon, PhD, Chiara M. Cattaneo, Sara F. Vieira, Emre Karakoc, Shriram Bhosle, Thomas W. Battaglia, Sarah Consonni, Timotheus You Fu Halim, Emile Voest, Mathew Garnett, Matthew Coelho

https://www.sciencedirect.com/science/article/pii/S266637912500638X?via%3Dihub

www.sciencedirect.com

1.0 CME Opportunity | ¹⁸F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma

This publication is available as a 1.0 CME-accredited educational activity, making it a strong option for clinicians looking to combine continuing medical education with an in-depth scientific update.

The article systematically reviews the role of ¹⁸F-FDG PET/CT across the full clinical spectrum of head and neck squamous cell carcinoma (HNSCC):

• Initial staging and evaluation of occult primary tumors

• Assessment of cervical nodal disease, distant metastases, and synchronous malignancies

• Prognostic value of pre-treatment PET parameters

• PET/CT-guided radiation therapy planning and treatment adaptation

• Post-chemoradiotherapy assessment with high negative predictive value, helping reduce unnecessary neck dissections

• Emerging advances including radiomics, machine learning, PET/MRI, and non-FDG radiotracers

For imaging specialists and oncology professionals, this CME activity supports both clinical practice improvement and formal credit requirements.

Authors:

Carmelo Caldarella, Marina De Risi, Mariangela Massaccesi, Francesco Miccichè, Francesco Bussu, Jacopo Galli, Vittoria Rufini, Lucia Leccisotti

https://www.acapedia.com/article/18F-FDG-PET-CT-head-neck-carcinoma-evidence

Acapedia CME | Insights on 18F-FDG PET/CT in Head & Neck Carcinoma Earn CME credit with Acapedia! Explore comprehensive insights on 18F-FDG PET/CT in head and neck squamous cell carcinoma. Learn and earn today!

🧬 Chemotherapy & Biological Aging: Understanding the Epigenetic Impact

Chemotherapy remains a cornerstone of breast cancer treatment, yet its broader biological effects continue to be an important area of study. Research published in Epigenetics has examined how chemotherapy influences DNA methylation–based biological age, offering deeper insight into how cytotoxic therapies may interact with the ageing process.

Using peripheral blood samples from women undergoing breast cancer treatment, the study evaluated six well-established biological ageing markers—including GrimAge, PhenoAge, DunedinPACE, and telomere length—before and after the first cycle of chemotherapy.

📌 Highlighted Observations:

- Increases in several epigenetic age acceleration markers

- A measurable rise in the pace of ageing (DunedinPACE)

- Decreases in telomere length

- Findings remained consistent after adjusting for chronological age and race

These results contribute to the ongoing understanding that chemotherapy may influence pathways related to biological ageing—an important consideration for long-term survivorship planning and age-related health outcomes.

For clinicians, this article offers 1.0 AMA PRA Category 1 CME Credit™, as well as MOC or Patient Safety credit depending on specialty.

Acapedia CME | Chemotherapy's Impact on Biological Age in Breast Cancer Earn CME credit with Acapedia! Explore our research on chemotherapy's role in accelerating biological age in breast cancer patients. Read, learn, and earn today!

🔬 Revolutionizing Autoimmune Therapy Through Fc Engineering

A groundbreaking study published in Science by Andrew T. Jones, Alessandra E. Marino, Tetyana Martynyuk, Stylianos Bournazos, and Jeffrey Ravetch explores how fine-tuning antibody structure can drastically enhance therapeutic outcomes.

The research demonstrates that the anti-inflammatory activity of immunoglobulin G (IgG) is significantly amplified when type I and type II Fc receptors are co-engaged — specifically FcγRIIB and DC-SIGN.

By engineering a sialylated Fc fragment (V11 sFc) with enhanced affinity for the inhibitory receptor FcγRIIB, the team achieved comparable efficacy to intravenous immunoglobulin (IVIG) at 100× lower doses.

This discovery not only provides insight into the molecular mechanism of IVIG’s action but also paves the way for a new generation of anti-inflammatory biologics — more potent, accessible, and sustainable.

🧠 Key insights:

• Fc-engineered sialylated IgG shows 100-fold higher potency than standard IVIG.

• Co-engagement of FcγRIIB and DC-SIGN enhances IgG’s immunoregulatory activity.

• This dual-receptor interaction may redefine treatment paradigms for autoimmune disorders.

📄 Reference:

“The anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II Fc receptors”

https://www.science.org/doi/10.1126/science.adv2927

The anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II Fc receptors Intravenous immunoglobulin (IVIG) administered at high doses is used to treat a wide array of autoimmune diseases. Studies in murine models have identified that the anti-inflammatory activity of IVIG is dependent on sialylation of the N-linked glycan on ...